Terms: = Liver cancer AND FOXA1, TCF3A, 3169, ENSG00000129514, P55317, HNF3A, MGC33105 AND Prognosis
8 results:
1. Elevated foxa1 Expression Indicates Poor prognosis in liver cancer due to Its Effects on Cell Proliferation and Metastasis.
Liu Z; Wang Y; Aizimuaji Z; Ma S; Xiao T
Dis Markers; 2022; 2022():3317315. PubMed ID: 35968505
[TBL] [Abstract] [Full Text] [Related]
2. Opposing Roles of foxa1 and FoxA3 in Intrahepatic Cholangiocarcinoma Progression.
Thanan R; Kaewlert W; Sakonsinsiri C; Chaiprasert T; Armartmuntree N; Muengsaen D; Techasen A; Klanrit P; Lert-Itthiporn W; Pinlaor S; Pairojkul C
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32151057
[TBL] [Abstract] [Full Text] [Related]
3. MicroRNA-3064-5p sponged by MALAT1 suppresses angiogenesis in human hepatocellular carcinoma by targeting the foxa1/CD24/Src pathway.
Zhang P; Ha M; Li L; Huang X; Liu C
FASEB J; 2020 Jan; 34(1):66-81. PubMed ID: 31914639
[TBL] [Abstract] [Full Text] [Related]
4. foxa1
Liang J; Tian C; Zeng Y; Yang Q; Liu Y; Liu Y; Wu J; Hu Y; Gu F; Zhang K; Wang Y; Zhang Y; Liu L
Biochem Biophys Res Commun; 2019 Jun; 514(1):308-315. PubMed ID: 31036318
[TBL] [Abstract] [Full Text] [Related]
5. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/foxa1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract] [Full Text] [Related]
6. TXNDC9 promotes hepatocellular carcinoma progression by positive regulation of MYC-mediated transcriptional network.
Chen D; Zou J; Zhao Z; Tang X; Deng Z; Jia J; Liu S
Cell Death Dis; 2018 Oct; 9(11):1110. PubMed ID: 30382079
[TBL] [Abstract] [Full Text] [Related]
7. LRH-1 controls proliferation in breast tumor cells by regulating CDKN1A gene expression.
Bianco S; Jangal M; Garneau D; Gévry N
Oncogene; 2015 Aug; 34(34):4509-18. PubMed ID: 25435372
[TBL] [Abstract] [Full Text] [Related]
8. Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties.
Coulouarn C; Factor VM; Andersen JB; Durkin ME; Thorgeirsson SS
Oncogene; 2009 Oct; 28(40):3526-36. PubMed ID: 19617899
[TBL] [Abstract] [Full Text] [Related]
